weight regain after tirzepatide discontinuation withdrawal leads to 25% in 82.5% of adults Fractyl Health Reports Positive One-Year
Description
You can white-knuckle a calorie deficit, but your body fights back when inflammation is running the show
Wu JY, Tseng KJ, Lin YM
L.RoddickA

Because tirzepatide is a dual-action medication, some patients experience more intense GI side effects initially

The MHRA hasnt yet approved it, so it is not available in the UK, though a UK submission is expected
